510(k) · Cleared
ClearedSPECTRALIS with Flex Module
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Heidelberg Engineering GmbH · OBO Tomography, Optical Coherence
Cleared on Oct 11, 2024 as substantially equivalent to K223557 (Heidelberg Engineering GmbH, 2023) and 1 other predicate after a 168-day review. Its family tree reaches back 13 generations to 2002. 1 later device descends from it.
- Decided
- Oct 11, 2024
- Review
- 168 days
- Class
- Class II
- Product code
- OBO
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 13 generations to K012727 (2002). 31 ancestors in all, the oldest K946058 (1995). 1 later device descends from it, 1 citing it directly.
- Root · 13 generations backK012727 Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc. · 2002
- 9 generations between
- 3 generations backK192391 Spectralis HRA+OCT and VariantsHeidelberg Engineering GmbH · 2019
- 2 generations backK201252 Spectralis HRA+OCT and variantsHeidelberg Engineering GmbH · 2020
- 1 generation backK223557 SPECTRALIS HRA+OCT and variantsHeidelberg Engineering GmbH · 2023
- This deviceK241163 SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH · 2024
- Descendant · cites it directly · 0 of its ownK253837 SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH · 2026
Show all 13 generations
- Root · 13 generations backK012727 Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc. · 2002
- 12 generations backK030433 Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc. · 2003 · Recalled
- 11 generations backK033123 Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc. · 2004 · Recalled
- 10 generations backK063343 Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc. · 2006
- 9 generations backK071250 CA, Model: CamOptovue, Inc. · 2007
- 8 generations backK101505 Rtvue Model Rtvue 100Optovue, Inc. · 2010 · Recalled
- 7 generations backK120238 Rtvue XR OctOptovue, Inc. · 2012
- 6 generations backK153080 RTVue XR OCT Avanti with AngioVue SoftwareOptovue, Inc. · 2016
- 5 generations backK181594 Spectralis HRA+OCT and variants with OCT Angiography ModuleHeidelberg Engineering GmbH · 2018 · Recalled
- 4 generations backK182569 Spectralis HRA+OCT and variants with High Magnification ModuleHeidelberg Engineering GmbH · 2018
- 3 generations backK192391 Spectralis HRA+OCT and VariantsHeidelberg Engineering GmbH · 2019
- 2 generations backK201252 Spectralis HRA+OCT and variantsHeidelberg Engineering GmbH · 2020
- 1 generation backK223557 SPECTRALIS HRA+OCT and variantsHeidelberg Engineering GmbH · 2023
- This deviceK241163 SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH · 2024
Most influential descendants
Showing 1 of 1 · See all- K253837SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH · 2026 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −13 | K012727 | Humphrey OCT3 | Carl Zeiss Ophthalmic Systems, Inc. | 2002 | — |
| −12 | K030433 | Stratusoct with RNFL Normative Database | Carl Zeiss Meditec, Inc. | 2003 | 1 |
| −11 | K033123 | Stratusoct with RNFL & Macula Normative Database | Carl Zeiss Meditec, Inc. | 2004 | 1 |
| −10 | K063343 | Bioptigen Spectral Domain Ophthalmic Imaging System | Bioptigen, Inc. | 2006 | — |
| −9 | K071250 | CA, Model: Cam | Optovue, Inc. | 2007 | — |
| −8 | K101505 | Rtvue Model Rtvue 100 | Optovue, Inc. | 2010 | 1 |
| −7 | K120238 | Rtvue XR Oct | Optovue, Inc. | 2012 | — |
| −6 | K153080 | RTVue XR OCT Avanti with AngioVue Software | Optovue, Inc. | 2016 | — |
| −5 | K181594 | Spectralis HRA+OCT and variants with OCT Angiography Module | Heidelberg Engineering GmbH | 2018 | 2 |
| −4 | K182569 | Spectralis HRA+OCT and variants with High Magnification Module | Heidelberg Engineering GmbH | 2018 | — |
| −3 | K192391 | Spectralis HRA+OCT and Variants | Heidelberg Engineering GmbH | 2019 | — |
| −2 | K201252 | Spectralis HRA+OCT and variants | Heidelberg Engineering GmbH | 2020 | — |
| −1 | K223557 | SPECTRALIS HRA+OCT and variants | Heidelberg Engineering GmbH | 2023 | — |
| 0 (this device) | K241163 | SPECTRALIS with Flex Module | Heidelberg Engineering GmbH | 2024 | — |
| +1 | K253837 | SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex Module | Heidelberg Engineering GmbH | 2026 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1995 | 2 | 0 |
| 1998 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 0 |
| 2004 | 2 | 0 |
| 2005 | 1 | 0 |
| 2006 | 3 | 0 |
| 2010 | 1 | 0 |
| 2012 | 2 | 0 |
| 2016 | 1 | 0 |
| 2017 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in OBO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new OBO device
- #1 K250868 SPECTRALIS HRA+OCT and variantsscore 16.2 · 14 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K223557 | SPECTRALIS HRA+OCT and variantsSummary page 6…13 K241163 PRIMARY PREDICATE DEVICE SPECTRALIS HRA+OCT and variants (K223557), Heidelberg Engineering GmbH SECONDARY PREDICATE DEVICE Bioptigen ENVISU Spectral Domain Ophthalmic Imaging System (K120057) I… | 2023 |
| * | K120057 | Envisu Spectral Domain Ophthalmic Imaging System (Sdois)Summary page 6…ATE DEVICE SPECTRALIS HRA+OCT and variants (K223557), Heidelberg Engineering GmbH SECONDARY PREDICATE DEVICE Bioptigen ENVISU Spectral Domain Ophthalmic Imaging System (K120057) INDICATIONS FOR USE The SPECTRALIS with Flex Module is a non-contact ophthalmic diagnostic imaging device intended to aid in th… | 2012 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K253837 | SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex Module | 2026 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 22 years and passes through 5 companies; a new generation was cleared every 1.2 years on median.
- 4 of the 31 ancestors have a recall of any class.
- Of its descendants, K253837 (Heidelberg Engineering GmbH, 2026) has gone furthest, with 0 descendants of its own.
- 1 other device also cites its predicate K223557.
How does its category compare?
All OBO devicesOBO Tomography, Optical Coherence: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.
FDA decisions per year · OBO
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · OBO
125in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · OBO
1in 2022
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · OBO
4in 2025
MAUDE reports naming product code OBO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 0 |
| 2008 | 2 | — | 0 | 0 |
| 2009 | 4 | 151 | 0 | 0 |
| 2010 | 2 | — | 1 | 0 |
| 2011 | 2 | — | 2 | 0 |
| 2012 | 3 | 269 | 2 | 0 |
| 2013 | 2 | — | 0 | 2 |
| 2014 | 3 | 152 | 0 | 0 |
| 2015 | 1 | — | 0 | 0 |
| 2016 | 4 | 125 | 0 | 1 |
| 2017 | 4 | 118 | 0 | 0 |
| 2018 | 6 | 87 | 1 | 1 |
| 2019 | 5 | 249 | 0 | 0 |
| 2020 | 2 | — | 0 | 0 |
| 2021 | 1 | — | 1 | 1 |
| 2022 | 2 | — | 1 | 0 |
| 2023 | 7 | 262 | 0 | 3 |
| 2024 | 8 | 157 | 0 | 3 |
| 2025 | 3 | 125 | 0 | 4 |
| 2026 | 2 | — | 1 | — |
What is it indicated for?
The SPECTRALIS with Flex Module is a non-contact ophthalmic diagnostic imaging device intended to aid in the visualization of the posterior segment structures of the eye and vasculature of the retina and choroid. SPECTRALIS with Flex Module is intended for imaging of adults and pediatric patients in supine position.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K241163 · printed Nov 6, 2026
Cite this page
510(k) Report. “K241163: SPECTRALIS with Flex Module.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K241163
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026